HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of antitumor immunity ex vivo using dendritic cells transduced with fowl pox vector expressing MUC1, CEA, and a triad of costimulatory molecules (rF-PANVAC).

Abstract
The fowl pox vector expressing the tumor-associated antigens, mucin-1 and carcinoembryonic antigen in the context of costimulatory molecules (rF-PANVAC) has shown promise as a tumor vaccine. However, vaccine-mediated expansion of suppressor T-cell populations may blunt clinical efficacy. We characterized the cellular immune response induced by ex vivo dendritic cells (DCs) transduced with (rF)-PANVAC. Consistent with the functional characteristics of potent antigen-presenting cells, rF-PANVAC-DCs demonstrated strong expression of mucin-1 and carcinoembryonic antigen and costimulatory molecules, CD80, CD86, and CD83; decreased levels of phosphorylated STAT3, and increased levels of Tyk2, Janus kinase 2, and STAT1. rF-PANVAC-DCs stimulated expansion of tumor antigen-specific T cells with potent cytolytic capacity. However, rF-PANVAC-transduced DCs also induced the concurrent expansion of FOXP3 expressing CD4CD25 regulatory T cells (Tregs) that inhibited T-cell activation. Moreover, Tregs expressed high levels of Th2 cytokines [interleukin (IL)-10, IL-4, IL-5, and IL-13] together with phosphorylated STAT3 and STAT6. In contrast, the vaccine-expanded Treg population expressed high levels of Th1 cytokines IL-2 and interferon-γ and the proinflammatory receptor-related orphan receptor γt (RORγt) and IL-17A suggesting that these cells may share effector functions with conventional TH17 T cells. These data suggest that Tregs expanded by rF-PANVAC-DCs, exhibit immunosuppressive properties potentially mediated by Th2 cytokines, but simultaneous expression of Th1 and Th17-associated factors suggests a high degree of plasticity.
AuthorsBaldev Vasir, Corrine Zarwan, Rehan Ahmad, Keith D Crawford, Hassan Rajabi, Ken-Ichi Matsuoka, Jacalyn Rosenblatt, Zekui Wu, Heidi Mills, Donald Kufe, David Avigan
JournalJournal of immunotherapy (Hagerstown, Md. : 1997) (J Immunother) Vol. 35 Issue 7 Pg. 555-69 (Sep 2012) ISSN: 1537-4513 [Electronic] United States
PMID22892452 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • CD4 Antigens
  • Cancer Vaccines
  • Carcinoembryonic Antigen
  • Cytokines
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • Interleukin-2 Receptor alpha Subunit
  • Membrane Glycoproteins
  • Mucin-1
  • Nuclear Receptor Subfamily 1, Group F, Member 3
  • Panvac-VF
  • STAT Transcription Factors
Topics
  • CD4 Antigens (metabolism)
  • Cancer Vaccines (genetics, metabolism)
  • Carcinoembryonic Antigen (genetics, metabolism)
  • Cells, Cultured
  • Cytokines (metabolism)
  • Dendritic Cells (immunology, metabolism, virology)
  • Forkhead Transcription Factors (metabolism)
  • Fowlpox virus
  • Genetic Vectors
  • Humans
  • Interleukin-2 Receptor alpha Subunit (metabolism)
  • Lymphocyte Activation
  • Membrane Glycoproteins (genetics, metabolism)
  • Mucin-1 (genetics, metabolism)
  • Nuclear Receptor Subfamily 1, Group F, Member 3 (genetics, metabolism)
  • STAT Transcription Factors (genetics, metabolism)
  • T-Lymphocytes, Cytotoxic (immunology)
  • T-Lymphocytes, Regulatory (immunology)
  • Th1-Th2 Balance
  • Th17 Cells (immunology)
  • Transduction, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: